Budapest, Hungary

Gyula Lukács

This inventor holds 3 USPTO granted patents. Top assignees: Orion Corporation, Other. Active years: 2001-2003.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gyula Lukács: Innovator in Pharmaceutical Chemistry

Introduction

Gyula Lukács is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on the development of high-purity compounds that have potential applications in medicine.

Latest Patents

One of his latest patents is titled "High Purity (1R,2S,4R)-(-)-2-[(2'-{N,N-DIMETHYLAMINO}-ETHOXY)]-2-[PHENYL]-1,7,7-tri-METHYL-BICYCLO[2.2.1]HEPTANE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF AND A PROCESS FOR THE PREPARATION OF THESE COMPOUNDS AS WELL AS MEDICAMENTS CONTAINING 1 OR MORE OF THESE COMPOUNDS AND THEIR USE." This patent highlights his innovative approach to creating compounds that can be used in medicinal formulations.

Career Highlights

Throughout his career, Gyula has worked with various organizations, including Orion Corporation. His experience in the pharmaceutical industry has allowed him to develop a deep understanding of the complexities involved in drug formulation and development.

Collaborations

Gyula has collaborated with several professionals in his field, including Gyula Simig and Tibor Mezei. These collaborations have contributed to his success and the advancement of his research.

Conclusion

Gyula Lukács is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect his commitment to advancing medical science through high-quality compounds. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…